NASDAQ:RPTP - Raptor Pharmaceutical Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $9.00 0.00 (0.00 %) (As of 10/22/2018 04:00 PM ET)Previous Close$9.00Today's Range$9.00 - $9.0052-Week Range$2.94 - $9.05VolumeN/AAverage Volume1.42 million shsMarket Capitalization$767.76 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Raptor Pharmaceutical Corp. (Raptor) is a biopharmaceutical company. The Company is focused on developing and commercializing transformative treatments for people affected by diseases. Its product, PROCYSBI (cysteamine bitartrate) is a delayed-release capsules for the management of nephropathic cystinosis in adults and children of over six years. In Europe, PROCYSBI gastro-resistant hard capsules of cysteamine (as mercaptamine bitartrate), is indicated as an orphan medicinal product for the management of nephropathic cystinosis. Its QUINSAIR is a formulation of the antibiotic drug levofloxacin, suitable for inhalation via a nebulizer. It is engaged in developing MP-376 for non-CF bronchiectasis (BE) and nontuberculous mycobacteria (NTM) lung infections. It is also engaged in developing RP105 and RP106 for various diseases. Receive RPTP News and Ratings via Email Sign-up to receive the latest news and ratings for RPTP and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryBiotechnology SectorN/A SymbolNASDAQ:RPTP CUSIP75382F10 Webwww.horizonpharma.com Phone+1-415-4086200 Debt Debt-to-Equity Ratio1.33 Current Ratio3.57 Quick Ratio3.30 Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net Margins-43.75% Return on Equity-77.01% Return on Assets-15.64% Miscellaneous Employees158 Outstanding Shares85,310,000Market Cap$767.76 million Raptor Pharmaceutical (NASDAQ:RPTP) Frequently Asked Questions What is Raptor Pharmaceutical's stock symbol? Raptor Pharmaceutical trades on the NASDAQ under the ticker symbol "RPTP." How were Raptor Pharmaceutical's earnings last quarter? Raptor Pharmaceutical Corp (NASDAQ:RPTP) issued its quarterly earnings results on Thursday, August, 4th. The biotechnology company reported ($0.16) EPS for the quarter, beating analysts' consensus estimates of ($0.18) by $0.02. The biotechnology company had revenue of $32.05 million for the quarter, compared to analyst estimates of $28.52 million. Raptor Pharmaceutical had a negative return on equity of 77.01% and a negative net margin of 43.75%. The company's quarterly revenue was up 37.4% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.17) earnings per share. View Raptor Pharmaceutical's Earnings History. How do I buy shares of Raptor Pharmaceutical? Shares of RPTP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Raptor Pharmaceutical's stock price today? One share of RPTP stock can currently be purchased for approximately $9.00. How big of a company is Raptor Pharmaceutical? Raptor Pharmaceutical has a market capitalization of $767.76 million. Raptor Pharmaceutical employs 158 workers across the globe. What is Raptor Pharmaceutical's official website? The official website for Raptor Pharmaceutical is http://www.horizonpharma.com/. How can I contact Raptor Pharmaceutical? Raptor Pharmaceutical's mailing address is 7 Hamilton Lndg Ste 100, NOVATO, CA 94949-8283, United States. The biotechnology company can be reached via phone at +1-415-4086200. MarketBeat Community Rating for Raptor Pharmaceutical (NASDAQ RPTP)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 216 (Vote Outperform)Underperform Votes: 232 (Vote Underperform)Total Votes: 448MarketBeat's community ratings are surveys of what our community members think about Raptor Pharmaceutical and other stocks. Vote "Outperform" if you believe RPTP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RPTP will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 10/22/2018 by MarketBeat.com StaffFeatured Article: What is a conference call?